The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Abstract
Background and Purpose— The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy of intraarterial infusion of urokinase (UK) in patients with stroke within 6 hours of onset. Methods— Patients with ischemic stroke presenting within 6 hours of onset and displaying occlusions of the M1 or M2 portion of the middle cerebral artery on carotid angiography were randomized to the UK or control groups. Clinical outcome was assessed by the modified Rankin Scale, National Institutes of Health Stroke Scale, and Barthel Index. Results— The Independent Monitoring Committee recommended stopping the trial after approval of intravenous infusion of recombinant tissue plasminogen activator in Japan. A total of 114 patients underwent randomization, 57 patients in each group. Background characteristics were comparable between the 2 groups. The primary end point of favorable outcome (modified Rankin Scale 0 to 2) at 90 days was somewhat more frequent in the UK group than in the control group (49.1% and 38.6%, OR: 1.54, 95% CI: 0.73 to 3.23) but did not reach a significant level ( P =0.345). However, excellent functional outcome (modified Rankin Scale 0 to 1) at 90 days, a preplanned secondary end point, was more frequent in the UK group than in the control group (42.1% and 22.8%, P =0.045, OR: 2.46, 95% CI: 1.09 to 5.54). There were significantly more patients with National Institutes of Health Stroke Scale 0 or 1 at 90 days in the UK group than the control group ( P =0.017). The 90-day cumulative mortality was 5.3% in the UK group and 3.5% in the control group ( P =1.000), and intracerebral hemorrhage within 24 hours of treatment occurred in 9% and 2%, respectively ( P =0.206). Conclusions— The trial was aborted prematurely and the primary end point did not reach statistical significance. Nevertheless, the secondary analyses suggested that intraarterial fibrinolysis has the potential to increase the likelihood of excellent functional outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., Pessin, M., Ahuja, A., Callahan, F., Clark, W. M., et al. (1999) · JAMA · doi:10.1001/jama.282.21.2003 · Cited by 3,073
Albers, G. W., Thijs, V. N., Wechsler, L., Kemp, S., Schlaug, G., Skalabrin, E., Bammer, R., Kakuda, W., Lansberg, M. G., Shuaib, A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20976 · Cited by 1,268
del Zoppo, G. J., Higashida, R. T., Furlan, A. J., Pessin, M. S., Rowley, H. A., & Gent, M. (1998) · Stroke · doi:10.1161/01.str.29.1.4 · Cited by 1,239
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Intra-arterial Prourokinase for Acute Ischemic Stroke
Akins, P. T. (2000) · JAMA · doi:10.1001/jama.283.16.2102 · Cited by 792
Lewandowski, C. A., Frankel, M., Tomsick, T. A., Broderick, J., Frey, J., Clark, W., Starkman, S., Grotta, J., Spilker, J., Khoury, J., et al. (1999) · Stroke · doi:10.1161/01.str.30.12.2598 · Cited by 628
Furlan, A. J., Eyding, D., Albers, G. W., Al-Rawi, Y., Lees, K. R., Rowley, H. A., Sachara, C., Soehngen, M., Warach, S., & Hacke, W. (2006) · Stroke · doi:10.1161/01.str.0000217403.66996.6d · Cited by 540
Yamaguchi, T., Mori, E., Minematsu, K., Nakagawara, J., Hashi, K., Saito, I., & Shinohara, Y. (2006) · Stroke · doi:10.1161/01.str.0000227191.01792.e3 · Cited by 515
Self-citationThe European Cooperative Acute Stroke Study (ECASS)
Kaste, M., Fieschi, C., Hacke, W., Lesaffre, E., Verstraete, M., & Fröhlich, J. (1993) · Thrombolytic Therapy in Acute Ischemic Stroke II · doi:10.1007/978-3-642-78061-5_10 · Cited by 487
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
Mori, E., Yoneda, Y., Tabuchi, M., Yoshida, T., Ohkawa, S., Ohsumi, Y., Kitano, K., Tsutsumi, A., & Yamadori, A. (1992) · Neurology · doi:10.1212/wnl.42.5.976 · Cited by 472
Self-citationLocal intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.
del Zoppo, G. J., Ferbert, A., Otis, S. M., Brückmann, H., Hacke, W., Zyroff, J., Harker, L. A., & Zeumer, H. (1988) · Stroke · doi:10.1161/01.str.19.3.307 · Cited by 382
Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery.
Mori, E., Tabuchi, M., Yoshida, T., & Yamadori, A. (1988) · Stroke · doi:10.1161/01.str.19.7.802 · Cited by 362
Self-citationHemorrhagic cerebral infarction--a prospective study.
Hornig, C. R., Dorndorf, W., & Agnoli, A. L. (1986) · Stroke · doi:10.1161/01.str.17.2.179 · Cited by 333
Wardlaw, J. M., & Mielke, O. (2005) · Radiology · doi:10.1148/radiol.2352040262 · Cited by 308
Hemorrhagic transformation in cerebral embolism.
Okada, Y., Yamaguchi, T., Minematsu, K., Miyashita, T., Sawada, T., D, S. S. M., Fujishima, M., & Omae, T. (1989) · Stroke · doi:10.1161/01.str.20.5.598 · Cited by 305
Self-citationThomalla, G., Schwark, C., Sobesky, J., Bluhmki, E., Fiebach, J. B., Fiehler, J., Zaro Weber, O., Kucinski, T., Juettler, E., Ringleb, P. A., et al. (2006) · Stroke · doi:10.1161/01.str.0000204120.79399.72 · Cited by 235
Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease.
Zeumer, H., Hacke, W., & Ringelstein, E. B. (1983) · PubMed · Cited by 206
Local Intra-Arterial Thrombolysis in Acute Ischemic Stroke
Gönner, F., Remonda, L., Mattle, H., Sturzenegger, M., Ozdoba, C., Lövblad, K.-O., Baumgartner, R., Bassetti, C., & Schroth, G. (1998) · Stroke · doi:10.1161/01.str.29.9.1894 · Cited by 188
Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke
Yamaguchi, T., Hayakawa, T., & Kiuchi, H. (1993) · Cerebrovascular Diseases · doi:10.1159/000108714 · Cited by 152
Analysis of 16,922 Patients with Acute Ischemic Stroke and Transient Ischemic Attack in Japan
Kimura, K., Kazui, S., Minematsu, K., & Yamaguchi, T. (2004) · Cerebrovascular Diseases · doi:10.1159/000078749 · Cited by 145
Self-citationLodder, J., Kubat, B., & Broekman, J. (1986) · Stroke · doi:10.1161/01.str.17.4.626 · Cited by 126
Acute Intravenous–Intra-Arterial Revascularization Therapy for Severe Ischemic Stroke
Hill, M. D., Barber, P. A., Demchuk, A. M., et al. (2002) · Stroke · doi:10.1161/hs0102.101900 · Cited by 91
Thrombolytic Intervention in Acute Thrombotic and Embolic Stroke
del Zoppo, G., Pessin, M. S., Mori, E., & Hacke, W. (1991) · Seminars in Neurology · doi:10.1055/s-2008-1041241 · Cited by 80
Self-citationBendszus, M., Urbach, H., Ries, F., et al. (1998) · Neuroradiology · doi:10.1007/s002340050540 · Cited by 55
Some Clinical Aspects of Acute Stroke: Excellence in Clinical Stroke Award Lecture
Mohr, J. P. (1997) · Stroke · doi:10.1161/01.str.28.9.1835 · Cited by 30
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Pathophysiology and treatment of stroke: present status and future perspectives
Kuriakose, D., & Xiao, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207609 · Cited by 1,350
Endovascular Treatment for Acute Ischemic Stroke
Ciccone, A., Valvassori, L., Nichelatti, M., Sgoifo, A., Ponzio, M., Sterzi, R., & Boccardi, E. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213701 · Cited by 1,297
Metadata
- Authors
- Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., Miyamoto, S., Sasaki, M., & Inoue, T.
- Venue
- Stroke
- Published
- 2007-10
- Volume
- 38
- Issue
- 10
- Pages
- 2633-2639
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2012982706
- Cited by
- 481
- References
- 28
- FWCI
- 22.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.